Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$111.63

0.2 (0.18%)

21:03
08/22/19
08/22
21:03
08/22/19
21:03

Arbitration panel rules in favor of Eli Lilly in Adocia IP claim

A Chicago-based arbitration panel has ruled in favor of Eli Lilly in a claim filed by Adocia S.A. over the companies' prior collaboration on a rapid-acting insulin. The panel of three arbitrators ruled that Lilly acted appropriately regarding Adocia's intellectual property, and while they denied Lilly's smaller counterclaim, ruled that Lilly is not liable for damages. Lilly and Adocia signed a collaboration agreement in December 2014. Lilly terminated the agreement and discontinued future development, manufacturing, and commercialization related to the program in January 2017.

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

  • 23

    Oct

LLY Eli Lilly
$111.63

0.2 (0.18%)

06/11/19
JPMS
06/11/19
NO CHANGE
JPMS
Overweight
Eli Lilly Rewind data missed 'fairly high' expectations, says JPMorgan
JPMorgan analyst Chris Schott is not surprised by the weakness yesterday in shares of Eli Lilly as he believes the Rewind data came in below "fairly high" expectations. However, the analyst ultimately sees the data confirming a cardiovascular benefit for Trulicity and supporting "continued strong Trulicity/GLP-1 uptake." Further, Schott sees the tirzepatide data at the American Diabetes Association conference as continuing to highlight a potentially best in class efficacy profile for the product. Lilly remains the analyst's top pick in his pharma coverage.
07/11/19
RAJA
07/11/19
NO CHANGE
RAJA
Death of drug rebate rule a win for PBMs and distributors, says Raymond James
After multiple media outlets, including Politico, reported that the Trump Administration has decided to withdraw the drug rebate rule, Raymond James analyst Chris Meekins called the news "a win" for pharmacy benefit managers and drug distributors and "a slight negative" for the pharmaceutical makers. The cost of the proposal to the government was ultimately too high with little guarantee that list prices would go down, said Meekins. However, President Trump hinted something "major" on drug pricing was coming over the next week during his kidney care speech and the analyst thinks the President is planning to move forward with an executive order on pricing. Publicly traded pharmaceutical distributors include McKesson (MCK), Cardinal Health (CAH), Amerisource (ABC) and Patterson (PDCO). Owners of pharmacy benefit managers include CVS Health (CVS), UnitedHealth (UNH), Anthem (ANTM) and Cigna (CI). Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/17/19
MZHO
07/17/19
NO CHANGE
Target $103
MZHO
Buy
Amgen seen by Mizuho as 'most likely' buyer of Celgene's Otezla
In the wake of the recent announcement that Bristol-Myers (BMY) plans to divest Otezla as part of its deal to acquire Celgene (CELG), Mizuho analyst Salim Syed said he has received questions on who could be a realistic buyer. He believes the "most likely" buyer would be Amgen (AMGN), followed by Johnson & Johnson (JNJ), which he would label as a "likely" buyer. Syed identifies the "less likely, but possible" buyers as Eli Lilly (LLY) and Regeneron (REGN). The analyst, who said Otezla is worth anywhere from $5B-$10B depending on the view of sales and synergy potential, keeps a Buy rating and $103 price target on Celgene shares.
07/17/19
RAJA
07/17/19
NO CHANGE
RAJA
Investors shouldn't overreact to drug proposal headlines, says Raymond James
Raymond James analyst Chris Meekins noted that President Donald Trump has indicated an Executive Order on drug pricing is coming soon, but he believes investors "should be cautious not to overreact" to drug related proposal headlines as he "cannot think of a single proposal that was finalized and also survived a court challenge resulting in a negative impact on earnings" yet from the Trump Administration. Given the history of the current White House to date, Meekins said he is increasingly skeptical the Administration will get anything meaningful finalized and overcome legal challenges that will impact drugmakers' earnings before the 2020 election, he tells investors in a healthcare policy note. Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).

TODAY'S FREE FLY STORIES

16:10
09/20/19
09/20
16:10
09/20/19
16:10
General news
Treasury Market Summary »

Treasury Market Summary:…

AAPL

Apple

$218.51

-2.4 (-1.09%)

, MCD

McDonald's

$210.05

-0.51 (-0.24%)

16:08
09/20/19
09/20
16:08
09/20/19
16:08
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. markets closed out…

AAPL

Apple

$218.51

-2.4 (-1.09%)

MCD

McDonald's

$210.05

-0.51 (-0.24%)

FB

Facebook

$189.46

-0.69 (-0.36%)

FIT

Fitbit

$4.13

0.46 (12.55%)

GOOG

Alphabet

$1,230.65

-8.95 (-0.72%)

GOOGL

Alphabet Class A

$1,230.42

-7.79 (-0.63%)

WMT

Walmart

$116.92

-0.12 (-0.10%)

MO

Altria Group

$40.78

0.67 (1.67%)

BTI

British American Tobacco

$36.29

-0.21 (-0.58%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$71.50

-0.2 (-0.28%)

MDR

McDermott

$2.02

0.44 (27.85%)

CRC

California Resources

$11.08

1.18 (11.92%)

ROKU

Roku

$107.49

-26.22 (-19.61%)

W

Wayfair

$122.82

-5.845 (-4.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Oct

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

BPMX

BioPharmX

$0.39

0.008 (2.12%)

16:08
09/20/19
09/20
16:08
09/20/19
16:08
Hot Stocks
BioPharmX receives extension to regain compliance with NYSE »

BioPharmX received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKIS

Peak Resorts

$10.99

0.005 (0.05%)

, MTN

Vail Resorts

$235.28

1.31 (0.56%)

16:06
09/20/19
09/20
16:06
09/20/19
16:06
Hot Stocks
Peak Resorts holders approve merger pact for acquisition by Vail Resorts »

Peak Resorts, Inc. (SKIS)…

SKIS

Peak Resorts

$10.99

0.005 (0.05%)

MTN

Vail Resorts

$235.28

1.31 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

SPKE

Spark Energy

$10.07

0.06 (0.60%)

16:04
09/20/19
09/20
16:04
09/20/19
16:04
Syndicate
Breaking Syndicate news story on Spark Energy »

Spark Energy files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPKE

Spark Energy

$10.07

0.06 (0.60%)

16:02
09/20/19
09/20
16:02
09/20/19
16:02
Syndicate
Breaking Syndicate news story on Spark Energy »

Spark Energy files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTFT

Future FinTech

$1.01

-0.02 (-1.95%)

16:01
09/20/19
09/20
16:01
09/20/19
16:01
Hot Stocks
Future FinTech submits compliance plan to Nasdaq »

Future FinTech Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SALM

Salem Media

$1.65

-0.115 (-6.52%)

15:34
09/20/19
09/20
15:34
09/20/19
15:34
Syndicate
Breaking Syndicate news story on Salem Media »

Salem Media files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SALM

Salem Media

$1.65

-0.115 (-6.52%)

15:34
09/20/19
09/20
15:34
09/20/19
15:34
Syndicate
Breaking Syndicate news story on Salem Media »

Salem Media files $40M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRC

Bank of Marin

$42.89

-0.63 (-1.45%)

15:31
09/20/19
09/20
15:31
09/20/19
15:31
Hot Stocks
Bank of Marin engages Korn Ferry for CEO successor search »

Bank of Marin and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$5.78

-0.08 (-1.37%)

15:30
09/20/19
09/20
15:30
09/20/19
15:30
Options
Long-term deep otm puts in Transocean see action »

Long-term deep otm puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$155.47

-0.26 (-0.17%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:29
09/20/19
09/20
15:29
09/20/19
15:29
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT),…

IWM

iShares Trust Russell 2000 Index Fund

$155.47

-0.26 (-0.17%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/20/19
09/20
15:17
09/20/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TD

Toronto-Dominion

$57.84

0.27 (0.47%)

, DB

Deutsche Bank

$8.02

-0.05 (-0.62%)

15:16
09/20/19
09/20
15:16
09/20/19
15:16
Periodicals
TD accepted Epstein accounts after Deutsche cut ties, Bloomberg says »

Canadian lender TD Bank…

TD

Toronto-Dominion

$57.84

0.27 (0.47%)

DB

Deutsche Bank

$8.02

-0.05 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/20/19
09/20
15:16
09/20/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$6.33

0.15 (2.43%)

15:15
09/20/19
09/20
15:15
09/20/19
15:15
Options
Adverum Biotechnologies put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

SPY

SPDR S&P 500 ETF Trust

$299.02

-0.656381 (-0.22%)

, SPX

S&P 500

$0.00

(0.00%)

15:09
09/20/19
09/20
15:09
09/20/19
15:09
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX) at…

SPY

SPDR S&P 500 ETF Trust

$299.02

-0.656381 (-0.22%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,232.55

-7.05 (-0.57%)

, GOOGL

Alphabet Class A

$1,232.30

-5.91 (-0.48%)

15:04
09/20/19
09/20
15:04
09/20/19
15:04
Hot Stocks
YouTube CEO apologizes to creators for 'new approach to verification' »

YouTube CEO Susan…

GOOG

Alphabet

$1,232.55

-7.05 (-0.57%)

GOOGL

Alphabet Class A

$1,232.30

-5.91 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

MGM

MGM Resorts

$28.92

-0.14 (-0.48%)

, BX

Blackstone

$52.46

-0.45 (-0.85%)

15:00
09/20/19
09/20
15:00
09/20/19
15:00
Periodicals
MGM Resorts in talks to sell Circus Circus casino to Phil Ruffin, Bloomberg says »

MGM Resorts (MGM) is in…

MGM

MGM Resorts

$28.92

-0.14 (-0.48%)

BX

Blackstone

$52.46

-0.45 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TGT

Target

$107.36

-0.48 (-0.45%)

15:00
09/20/19
09/20
15:00
09/20/19
15:00
Options
Buyer pays 12c over parity for deep in the money expiring Sep 87.5 calls »

Buyer pays 12c over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CAG

Conagra Brands

$29.95

0.3 (1.01%)

14:55
09/20/19
09/20
14:55
09/20/19
14:55
Options
ConAgra put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

14:50
09/20/19
09/20
14:50
09/20/19
14:50
General news
Fed's Kaplan said he backed the Fed's rate cuts in September and July »

Fed's Kaplan said he…

FB

Facebook

$189.71

-0.44 (-0.23%)

14:48
09/20/19
09/20
14:48
09/20/19
14:48
Hot Stocks
Facebook says has suspended 'tens of thousands' of apps over data use »

In a blog post, Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

SKT

Tanger Factory

$15.90

0.13 (0.82%)

14:35
09/20/19
09/20
14:35
09/20/19
14:35
Options
Tanger Factory put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
09/20/19
09/20
14:35
09/20/19
14:35
General news
Action Economics Survey results: »

Action Economics Survey…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.